Performance vs S&P 500

03
Tracked Q1 2025–Q2 2026 +186.9%
S&P 500 total return (same window) +37.0%
Excess return +149.9%

Annualized: +132.5% · S&P 500: +28.7%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 96.1% · Options excluded: 7.6%

Sector breakdown

04
Healthcare 98.4%
Other/Unmapped 1.6%

Full portfolio 68 positions

05
Type Streak 8Q trend
ERAS Erasca, Inc. - Common Stock $222,588,000 9.58% 12,150,000 $42,181,000 Up ×1
ABVX Abivax SA - American Depositary Shares $136,458,240 5.87% 1,024,000 $61,296,990 Up ×2
RVMD Revolution Medicines, Inc. - Common Stock $131,096,000 5.64% 700,000 $-63,404,000 Down ×1
IDYA IDEAYA Biosciences, Inc. - Common Stock $111,810,000 4.81% 3,000,000 $-3,144,000 Down ×1
BNTX BioNTech SE - American Depositary Shares $94,445,750 4.07% 1,015,000
VERA Vera Therapeutics, Inc. - Class A Common Stock $94,402,000 4.06% 2,200,000 Up ×1
TNGX Tango Therapeutics, Inc. - Common Stock $89,091,000 3.84% 2,850,000 $26,331,000 Down ×2
PRAX Praxis Precision Medicines, Inc. - Common Stock $87,045,400 3.75% 260,000 $-4,778,750 Down ×2
CLDX Celldex Therapeutics, Inc. - Common Stock $78,141,000 3.36% 2,100,000 $63,867,000 Up ×2
DNTH Dianthus Therapeutics, Inc. - Common Stock $77,984,000 3.36% 800,000 $44,416,000 Up ×3
CGON CG Oncology, Inc. - Common stock $71,050,000 3.06% 1,000,000 $32,134,000 Up ×2
IRON Disc Medicine, Inc. - Common Stock $63,997,500 2.76% 875,000 $28,191,100 Up ×3
MAZE Maze Therapeutics, Inc. - Common Stock $57,740,400 2.49% 1,935,000 $20,875,650 Up ×2
DYN Dyne Therapeutics, Inc. - Common Stock $56,635,500 2.44% 2,550,000 $31,253,500 Up ×2
MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares $52,082,250 2.24% 2,675,000 $24,122,250 Up ×1
OCUL Ocular Therapeutix, Inc. - Common Stock $52,046,000 2.24% 5,300,000 $19,436,500 Up ×4
DSGN Design Therapeutics, Inc. - Common Stock $43,410,000 1.87% 3,000,000 $22,662,000 Up ×1
OLMA Olema Pharmaceuticals, Inc. - Common Stock $40,143,026 1.73% 3,208,875 $-7,701,300
BLTE Belite Bio, Inc - American Depositary Shares $38,496,250 1.66% 250,000 Up ×1
ACHV Achieve Life Sciences, Inc. - Common Shares $35,425,250 1.53% 5,425,000 Up ×1
TRVI Trevi Therapeutics, Inc. - Common Stock $35,062,000 1.51% 1,880,000 $6,430,000 Down ×1
COGT Cogent Biosciences, Inc. - Common Stock $34,830,000 1.50% 900,000
AVBP ArriVent BioPharma, Inc. - Common Stock $34,740,000 1.50% 1,000,000 $26,665,500 Up ×1
CBIO Crescent Biopharma, Inc. - Common Stock $34,200,000 1.47% 1,900,000 $25,336,475 Up ×1
CMPS COMPASS Pathways Plc - American Depository Shares $31,837,500 1.37% 2,250,000
MLYS Mineralys Therapeutics, Inc. - Common Stock $28,329,000 1.22% 1,050,000 Up ×1
REPL Replimune Group, Inc. - Common Stock $27,675,000 1.19% 2,500,000 Up ×1
XENE Xenon Pharmaceuticals Inc. - Common Shares $27,162,000 1.17% 450,000 $994,500
GPCR Structure Therapeutics Inc. - American Depositary Shares $26,835,000 1.16% 500,000 $2,735,000
IMVT Immunovant, Inc. - Common Stock $25,622,450 1.10% 665,000 $-1,080,550 Down ×2
JBIO Jade Biosciences, Inc. - Common Stock $24,997,500 1.08% 1,125,000 $19,377,500 Up ×2
ELVN Enliven Therapeutics, Inc. - Common Stock $23,598,750 1.02% 465,000 $2,430,750 Down ×1
MANE Veradermics, Incorporated Common Stock $22,129,200 0.95% 180,000 $20,550,450 Up ×1
AVTX Avalo Therapeutics, Inc. - Common Stock $21,252,000 0.91% 1,150,000 $16,773,000 Up ×1
RCUS Arcus Biosciences, Inc. Common Stock $20,039,500 0.86% 650,000 $-5,880,500 Down ×1
SMMT Summit Therapeutics Inc. - Common Stock $19,669,500 0.85% 1,350,000 Up ×1
IMCR Immunocore Holdings plc - American Depositary Shares $19,050,000 0.82% 600,000 $-26,175,000 Down ×1
LBRX LB Pharmaceuticals Inc - Common Stock $18,986,175 0.82% 585,000 $-3,577,725 Down ×2
NERV Minerva Neurosciences, Inc - Common Stock $18,252,712 0.79% 3,288,777 $-1,117,663 Up ×1
SNSE Sensei Biotherapeutics, Inc. - Common Stock $18,050,500 0.78% 722,020 $17,104,900 Up ×1
CRSP CRISPR Therapeutics AG - Common Shares $16,362,000 0.70% 300,000 Up ×1
DBVT DBV Technologies S.A. - American Depositary Shares $15,006,000 0.65% 915,000
Unknown issuer (CUSIP: 698955101) $14,369,250 0.62% 525,000 Up ×1
RYTM Rhythm Pharmaceuticals, Inc. - Common Stock $13,878,750 0.60% 125,000 $-25,257,750 Down ×1
VOR Vor Biopharma Inc. - Common Stock $11,966,500 0.52% 650,000 $-1,413,500 Down ×1
SRRK Scholar Rock Holding Corporation - Common Stock $11,000,000 0.47% 200,000
IMMX Immix Biopharma, Inc. - Common Stock $10,310,000 0.44% 1,000,000 $-849,750 Down ×1
QTTB Q32 Bio Inc. - Common Stock $10,192,000 0.44% 800,000 Up ×1
Unknown issuer (CUSIP: 67613T104) $9,761,681 0.42% 521,736 Up ×1
ANNX Annexon, Inc. - common stock $8,565,000 0.37% 1,500,000
EDIT Editas Medicine, Inc. - Common Stock $7,199,280 0.31% 2,222,000 Up ×1
RLAY Relay Therapeutics, Inc. - Common Stock $6,548,500 0.28% 350,000 $-914,000 Down ×1
ACAD ACADIA Pharmaceuticals Inc. - Common Stock $6,325,000 0.27% 250,000 $-10,370,000 Down ×2
AMLX Amylyx Pharmaceuticals, Inc. - Common Stock $6,286,000 0.27% 350,000 $-3,444,000 Down ×3
HELP Cybin Inc. - Common Stock $4,957,500 0.21% 750,000 Up ×1
OKUR OnKure Therapeutics, Inc. - Class A Common Stock $4,395,179 0.19% 963,855 Up ×1
TENX Tenax Therapeutics, Inc. - Common Stock $4,365,000 0.19% 300,000 $-5,628,750 Down ×1
DFTX Definium Therapeutics, Inc. - Common Shares $3,763,200 0.16% 80,000 Up ×1
UNCY Unicycive Therapeutics, Inc. - Common Stock $2,221,010 0.10% 473,563 $-895,035
PTN Palatin Technologies, Inc. - Common Stock $1,402,700 0.06% 130,000 $-1,036,100 Down ×1
QURE uniQure N.V. - Ordinary Shares $1,381,800 0.06% 30,000
Unknown issuer (CUSIP: G50765109) $1,136,000 0.05% 100,000 Up ×1
Unknown issuer (CUSIP: G75226103) $1,070,000 0.05% 100,000 Up ×1
ACRS Aclaris Therapeutics, Inc. - Common Stock $1,058,000 0.05% 200,000 $-817,000 Down ×5
LGVN Longeveron Inc. - Class A Common stock $904,761 0.04% 1,287,000 Up ×1
GUTS Fractyl Health, Inc. - Common Stock $794,400 0.03% 1,000,000 $336,600
SEPN Septerna, Inc. - Common Stock $788,623 0.03% 23,548 $222,765
Unknown issuer (CUSIP: G0375M101) $508,000 0.02% 50,000 Up ×1

Conviction holdings

08

Positions increased for 3+ consecutive quarters.

Share counts are as reported in 13F filings (not split-adjusted)

SecurityValue% of portfolioStreak
DNTH $77,984,000 3.36% up ×3
IRON $63,997,500 2.76% up ×3
OCUL $52,046,000 2.24% up ×4

Biggest new bets

09

New positions opened this quarter, largest first.

SecurityValueShares% of portfolio
BNTX $94,445,750 1,015,000 4.07%
VERA $94,402,000 2,200,000 4.06%
BLTE $38,496,250 250,000 1.66%
ACHV $35,425,250 5,425,000 1.53%
COGT $34,830,000 900,000 1.50%
CMPS $31,837,500 2,250,000 1.37%
MLYS $28,329,000 1,050,000 1.22%
REPL $27,675,000 2,500,000 1.19%
SMMT $19,669,500 1,350,000 0.85%
CRSP $16,362,000 300,000 0.70%
DBVT $15,006,000 915,000 0.65%
Unknown issuer (CUSIP: 698955101) $14,369,250 525,000 0.62%
SRRK $11,000,000 200,000 0.47%
QTTB $10,192,000 800,000 0.44%
Unknown issuer (CUSIP: 67613T104) $9,761,681 521,736 0.42%

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
RVMD Trimmed -1.3M -$63.4M
ABVX Bought more +349K +$61.3M
DNTH Bought more +400K +$44.4M
ERAS Bought more +1.0M +$42.2M
CGON Bought more +425K +$32.1M
DYN Bought more +1.1M +$31.3M
IRON Bought more +315K +$28.2M
AVBP Bought more +650K +$26.7M
TNGX Trimmed -150K +$26.3M
IMCR Trimmed -900K -$26.2M

1 position hidden — reported move looks larger than the position itself (data completeness check)

Exited positions

11

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarterShares beforeValue beforePrice since exit
TERN June 30, 2026 2,000,000 $105,440,000 No longer tracked
CNTA June 30, 2026 2,125,000 $84,405,000 No longer tracked
XBI Sept. 30, 2025 1,000,000 $82,930,000 54.1%
CDTX March 31, 2026 310,000 $68,475,900 No longer tracked
CYTK June 30, 2026 875,000 $57,671,250 -23.0%
AKRO Dec. 31, 2025 1,200,000 $56,976,000 No longer tracked
ARVN Dec. 31, 2025 5,575,000 $47,499,000 -37.5%
UTHR June 30, 2026 80,000 $47,438,400 0.0%
MDGL June 30, 2026 85,000 $44,494,950 -7.0%
BIIB June 30, 2026 200,000 $36,666,000 1.8%
RNA March 31, 2026 500,000 $36,065,000 -41.4%
NUVL June 30, 2025 500,000 $35,460,000 No longer tracked
JAZZ March 31, 2026 200,000 $34,000,000 24.7%
TYRA June 30, 2026 850,000 $32,555,000 -36.0%
TEVA Sept. 30, 2025 1,500,000 $25,140,000 95.7%
APLS March 31, 2026 1,000,000 $25,120,000 No longer tracked
UTHR Sept. 30, 2025 85,000 $24,424,750 29.2%
XENE June 30, 2025 650,000 $21,807,500 21.5%
PTGX Dec. 31, 2025 300,000 $19,929,000 60.4%
NAMS June 30, 2026 600,000 $19,206,000 -31.5%
NBIX Sept. 30, 2025 150,000 $18,853,500 2.0%
MIRM June 30, 2026 200,000 $18,476,000 -29.2%
BNTX June 30, 2025 200,000 $18,212,000 -9.0%
ETNB June 30, 2025 2,500,000 $18,175,000 No longer tracked
SLNO June 30, 2025 250,000 $17,862,500 No longer tracked
PCVX June 30, 2026 300,000 $17,433,000 -2.8%
CMPX June 30, 2026 3,150,000 $16,663,500 -60.9%
QURE March 31, 2026 675,000 $16,152,750 43.5%
MDGL Sept. 30, 2025 50,000 $15,132,000 8.9%
KNSA March 31, 2026 350,000 $14,437,500 57.4%
JANX June 30, 2026 1,000,000 $13,900,000 10.2%
KRYS Sept. 30, 2025 100,000 $13,746,000 82.6%
KROS Dec. 31, 2025 850,000 $13,447,000 -44.2%
GERN June 30, 2025 8,000,000 $12,720,000 -14.9%
ALKS June 30, 2026 350,000 $12,376,000 -20.3%
CLDX Sept. 30, 2025 600,000 $12,210,000 22.3%
ORIC June 30, 2026 950,000 $12,036,500 12.7%
CRNX June 30, 2025 350,000 $11,739,000 No longer tracked
KYMR March 31, 2026 130,000 $10,115,300 28.9%
BHVN Sept. 30, 2025 700,000 $9,877,000 -14.3%
XNCR Sept. 30, 2025 1,250,000 $9,825,000 111.8%
NRIX March 31, 2026 500,000 $9,485,000 48.3%
MLTX Sept. 30, 2025 200,000 $9,440,000 59.1%
IMTX March 31, 2026 850,000 $8,925,000 -22.9%
LEGN Sept. 30, 2025 250,000 $8,872,500 -43.1%
SLNO June 30, 2026 250,000 $8,370,000 No longer tracked
LRMR Dec. 31, 2025 2,500,000 $8,075,000 -22.3%
ACLX March 31, 2026 115,000 $7,498,000 No longer tracked
COGT Dec. 31, 2025 500,000 $7,180,000 -12.7%
IMRX Dec. 31, 2025 950,000 $6,650,000 -38.1%
CRVS June 30, 2026 450,000 $6,583,500 -27.0%
SRRK Dec. 31, 2025 175,000 $6,517,000 6.3%
MGTX June 30, 2026 700,000 $6,062,000 -20.1%
ANNX Sept. 30, 2025 2,410,000 $5,784,000 37.4%
CMPS June 30, 2025 2,000,000 $5,720,000 325.0%
MTSR Sept. 30, 2025 200,000 $5,690,000 No longer tracked
EPRX Dec. 31, 2025 900,000 $5,310,000 -4.1%
VSTM June 30, 2026 1,000,000 $5,300,000 101.6%
NGNE March 31, 2026 195,000 $4,017,000 27.2%
BCAX Sept. 30, 2025 400,000 $3,716,000 11.7%
ATXS Dec. 31, 2025 500,000 $3,640,000 No longer tracked
AVTE June 30, 2025 1,400,000 $3,514,000 No longer tracked
PEPG Dec. 31, 2025 750,000 $3,465,000 -65.0%
DAWN March 31, 2026 300,000 $2,796,000 No longer tracked
IBIO June 30, 2026 1,300,000 $2,470,000 -35.7%
RAPP Sept. 30, 2025 208,910 $2,375,307 8.3%
ESPR Dec. 31, 2025 750,000 $1,987,500 No longer tracked
PHVS June 30, 2026 65,000 $1,836,250 -9.8%
ALEC Dec. 31, 2025 500,000 $1,480,000 16.0%
GLYC June 30, 2025 5,400,000 $1,134,000 No longer tracked
MREO March 31, 2026 1,850,000 $770,895 15.1%
ALLK June 30, 2025 2,900,000 $660,040 No longer tracked
DBVT March 31, 2026 25,000 $479,250 -49.5%
ARTV June 30, 2025 145,089 $435,267 352.3%
SLDB June 30, 2025 100,000 $370,000 40.7%
NUVBWS March 31, 2026 66,666 $22,000 No longer tracked